| Description: |
Stem Cells USA & Regenerative Medicine Congress
September 13-15, 2010
Philadelphia, PA
Over the past few months, the regenerative medicine industry has experienced significant regulatory changes, unprecedented levels of investment from big pharma, enhanced media interest & genuine medical advances. As an unprecedented number of stem cell products near late stage clinical trials, industry leaders must identify strategies & nourish relationships which will fast track research, development & commercialization of stem cell & regenerative therapies.
After attending Stem Cells USA & Regenerative Medicine Congress, you will be able to:
-
Identify partnership opportunities with big pharmas, research institutions, and other biotechs
-
Select optimal business model for your science platform
-
Recognize tools and technologies to overcome manufacturing hurdlesDistinguish the different between autologous and allogeneic business models
-
Obtain funds through venture capital, big pharma, and non-profit organizations
-
Understand the steps of mergers and acquisitions due diligence
-
Evaluate and forecast the value of your biotech investment
-
Manage intellectual property patent law and licensing issues
-
Identify novel technology and their market potential
-
Understand the utilization of iPS cells and future implications, including IP issues
-
Receive technology and science updates by therapeutic applications
For more information, click here. |
